Skip to main content

GOLDMAN SACHS GROUP INC

Position in AZN — Astrazeneca PLC

CIK 886982 NEW YORK, NY

Position in AZN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,847,353,128
-$244,331,029 QoQ
Shares Held
9,742,396
-8.1% QoQ
Ownership
0.628%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#25
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 82% Shared 1% None 17%

Common Shares in AZN Over Time

Shares Held

Position Value (USD)

Derivatives in AZN

reported options exposure · as of Jun 30, 2026
CallValue
$37,924,000
CallShares
200,000
PutValue
$19,322,278
PutShares
101,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $29,799,350,964 across 16 Drug Manufacturers - General names. AZN ranks #5 (6.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 AZN
Astrazeneca PLC
This page
9,742,396 $1,847,353,128

All Filings in AZN

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $37,924,000 200,000
2026-06-30 $1,847,353,128 9,742,396
2026-06-30 $19,322,278 101,900
2026-03-31 $2,091,684,157 10,605,842
2026-03-31 $58,771,560 298,000
2026-03-31 $34,888,218 176,900